Supporting this, a study on canine insulinoma metastases reported a 20–70-fold upregulation of PRSS2 transcripts, accompanied by localized expression of CD40–CD40L in the tumor microenvironment  [32]. The gene discussed is CD40LG; the disease is pancreatic insulinoma.